tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

ADMArcher Daniels Midland

Consumer staples · Agricultural Products · NYSE
Compare with peers → Embed
The 10-K against last year's

204 changes: 58 added, 65 removed, 79 reworded, 2 quiet changes

10-K Feb 17, 2026 vs Feb 20, 2025
Risk FactorsRedline ↓
46.6%
of the text changed · 7,608 words now
44.1%
of the text changed · 8,281 words now
Legal ProceedingsRedline ↓
57.3%
of the text changed · 3,722 words now
Accounting PoliciesRedline ↓
22.6%
of the text changed · 4,993 words now

10-K 0000007084-26-000011 (2026-02-17) vs 10-K 0000007084-25-000011 (2025-02-20)

The redline

The paragraph that changed most in each section

Marked against last year's 10-K: cut words struck through, new words highlighted and underlined.

Legal Proceedings 220 words changed in this paragraph; it is 38% similar to last year's version.
Also Also, as previously disclosed, beginning on March 29, 2024, purported stockholders of the Company filed a number of related derivative lawsuits against certain current and former officers and directors of the Company, seeking unspecified damages. The derivative litigation is now initial actions were consolidated in the U.S. District Court for the District of Delaware. Defendants Separately, on January 14, 2025, a purported stockholder served a litigation demand on the Company’s Board of Directors, demanding that legal proceedings be brought against certain current and former officers and directors of the Company. On March 28, 2025, this stockholder filed a motion derivative lawsuit in the Court of Chancery of the State of Delaware (the “Court of Chancery”) against such current and former officers and directors of the Company (the “Litigation Demand Action”). Several other purported stockholders who did not make pre-suit demands filed additional derivative lawsuits in the Chancery Court of Delaware against certain current and former officers and directors of the Company, seeking unspecified damages; these actions have been consolidated in the Court of Chancery. The Litigation Demand Action was not included in the consolidation. On April 14, 2025, a purported stockholder filed a derivative lawsuit in the U.S. District Court for the Northern District of Illinois against certain current and former officers and directors of the Company, seeking unspecified damages; that action has been transferred to dismiss and consolidated with the consolidated complaint, which remains pending. action in the U.S. District Court for the District of Delaware. On July 3, 2025, a purported stockholder filed a lawsuit to compel inspection of ADM’s books and records. The Company is unable to predict the final outcome of this proceeding these proceedings with any reasonable degree of certainty.

Source: Item 3, via Note 20 – Legal Proceedings, 10-K 0000007084-26-000011 vs Item 3, via Note 20 – Legal Proceedings, 10-K 0000007084-25-000011

Risk Factors 204 words changed in this paragraph; it is 50% similar to last year's version.
As the The Company executes its growth strategy, through both is also focused on organic and inorganic growth, it may encounter growth and its success in achieving growth could be adversely affected by a broad range of risks which that could result in increased costs, decreased revenues, and delayed synergies. ADM’s growth also depends in part on innovation in products, processes and services. The Company’s ability to realize the anticipated benefits of its R&D efforts and other investments depends on a variety of factors, and may not result in new products and services at a rate or of a quality sufficient to gain market acceptance. In addition, the markets for these products may not develop or grow as the Company anticipates. Growth in new geographies outside the U.S. can expose the Company to volatile economic, political, and regulatory risks that may negatively impact its operations and ability to achieve its growth strategy. Expanding businesses where the Company has limited presence may expose the Company to risks related to the inability to identify an appropriate partner or target and favorable terms, inability to retain/hire strategic talent, or integration risks that may require significant management resources that would have otherwise been available for ongoing growth or operational initiatives. Acquisitions may involve unanticipated delays, costs, and other problems. Due diligence performed prior to an acquisition may not identify a material liability or issue that could impact the Company’s reputation or adversely affect results of operations resulting in a reduction of the anticipated acquisition benefits. Additionally, acquisitions may involve integration risks such as: internal control effectiveness, system integration risks, the risk of impairment charges related to goodwill and other intangibles, ability to retain acquired employees, and other unanticipated risks. The Company may fail to realize the operational or financial benefits expected from acquisitions, which may impact the Company’s growth strategy.

Source: Item 1A, 10-K 0000007084-26-000011 vs Item 1A, 10-K 0000007084-25-000011

MD&A 154 words changed in this paragraph; it is 33% similar to last year's version.
The decrease increase in cash provided by operating activities in 2024 2025 compared to 2023 2024 was primarily driven due to changes in net working capital, partially offset by lower earnings in the current year and changes in net working capital. year. Changes in net working capital were driven by changes in segregated investments, changes in inventory, changes in trade payables and changes in payables to brokerage customers. Segregated investments increased $693 million in the current year compared to an increase of $194 million in the prior year, driven by higher interest rates. Inventories decreased $162 million in the current year reflecting lower commodity pricing, customers and segregated investments, partially offset by increased volumes of on-hand inventories compared to a decrease of $2.9 billion changes in the prior-year, reflecting lower commodity pricing. Trade payables decreased $719 million in the current year compared to a decrease of $1.5 billion in the prior year, reflecting lower commodity pricing. Brokerage payables decreased $78 million in the current year compared to a decrease of $2.1 billion in the prior year which was driven by decreased trading activity in the Company’s futures commission accrued expenses and brokerage business. other payables.

Source: Item 7, 10-K 0000007084-26-000011 vs Item 7, 10-K 0000007084-25-000011

Accounting Policies 101 words changed in this paragraph; it is 52% similar to last year's version.
Archer-Daniels-Midland Company and its subsidiaries (the "Company" or "ADM") unlock unlocks the power of nature to enrich the quality of life. The Company is an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. ADM is also a premier human and animal nutrition provider, offering one of the industry's broadest portfolios of ingredients and solutions from nature. The Company is as well as a trailblazer leader in health and well-being, with an industry-leading range of products for consumers looking for new ways to live healthier lives. ADM is a cutting-edge innovator, guiding the way to a future of new consumer and industrial solutions. ADM is a leader in sustainability, scaling across entire value chains to help decarbonize the multiple industries it serves. Around the globe, the Company's innovation and expertise are meeting critical needs while nourishing quality of life and supporting a healthier planet. well-being products.

Source: Item 8, Note 1 – Summary of Significant Accounting Policies, 10-K 0000007084-26-000011 vs Item 8, Note 1 – Summary of Significant Accounting Policies, 10-K 0000007084-25-000011

Every change, by type

Sentences and paragraphs added, removed or reworded

Sentences and paragraphs of ADM's Risk Factors and MD&A, 10-K 2026-02-17 against 10-K 2025-02-20. Each links to the text at sec.gov.

RemovedRisk Factors
As previously disclosed, following a voluntary document request from the SEC relating to intersegment sales between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments, the Company conducted an internal investigation into certain accounting practices and procedures with respect to its Nutrition reporting segment, including as related to certain intersegment sales (the “Investigation”).

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedRisk Factors
The Company had historically disclosed in the footnotes to its financial statements that intersegment sales have been recorded at amounts approximating market. In connection with the Investigation, the Company identified certain intersegment sales that occurred between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments that were not recorded at amounts approximating market. The Company corrected those errors in its fiscal year 2023 Form 10-K, along with subsequently identified errors that the Company corrected in an amendment to its Annual Report on Form 10‑K for the fiscal year ended December 31, 2023 (the “FY2023 10-K/A”), and its Form 10-Qs for the first and second quarters of 2024, all of which were filed on November 18, 2024, to restate the segment disclosures included in those filings.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedRisk Factors
As a result of the Investigation, correction of identified errors and related events, the Company has experienced, and may continue to experience, a number of adverse impacts and risks, including, but not limited to:

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedRisk Factors
–the Company’s Board of Directors and senior management have been required to devote significant time to the Investigation, the correction of certain segment-specific historical financial information and related matters, resulting in potential management distraction from the operation of the business;

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedRisk Factors
–the price of the Company’s common stock has declined significantly, has been subject to fluctuations and could continue to fluctuate upon further announcements or actions;

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedRisk Factors
–the Company is facing securities litigation and could face additional litigation under federal and state securities laws or other claims arising from the Investigation, such litigation can be costly to defend, and if decided against the Company, such litigation could require the Company to pay substantial judgments or settlements;

Read it in 10-K 2025-02-20 at sec.gov ↗

Show the other 16
RemovedRisk Factors
–the three major credit rating agencies have maintained the Company’s credit ratings at investment grade levels with a negative outlook; however, if the ratings are downgraded, the Company’s access to the credit markets and its ability to fund its working capital and capital expenditures may be affected.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedRisk Factors
In addition, although the Company has taken certain actions in response to the findings of the Investigation, the Company could take new or different actions in addition to those taken to date if it determines those actions are appropriate. Such actions are uncertain and could have a material adverse impact on the Company’s business and the price of its common stock.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedRisk Factors
As previously disclosed, and as described more fully in Part II. Item 8. Note 20. Legal Proceedings of this report, the Company is under investigation by the United States Securities and Exchange Commission (“SEC”) and the Department of Justice (“DOJ”) relating to, among other things, intersegment sales between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments. The Company cannot predict when the SEC and DOJ investigations will be completed, nor can it predict the results of these investigations with any reasonable degree of certainty. Expenses incurred in connection with these investigations (which include substantial fees of lawyers and other professional advisors and potential obligations to indemnify officers and directors who are parties to these investigations) could adversely affect the Company’s results of operations and liquidity position. The Company may be required to pay material fines, consent to injunctions on future conduct or be subject to other penalties, each of which could have a material adverse effect on its business, results of operations, financial condition and liquidity. These government investigations also may adversely affect the Company’s ability to obtain, and/or increase the cost of obtaining, directors’ and officers’ liability insurance and/or other types of insurance. In addition, the findings and outcomes of the Investigation as well as the government investigations could result in additional litigation or actions taken by third parties against the Company. The effects and results of such other litigation or actions may have a materially adverse effect on the Company’s business, results of operations, financial condition and liquidity.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedMD&A
The Productivity pillar includes (1) partnering across various global teams including procurement, supply chain, operations, and commercial to optimize costs and improve both production volumes and demand fulfillment across the enterprise; (2) implementation of improved standardized business processes and aggressive management of selling, general, and administrative expenses and Corporate costs; (3) portfolio simplification to improve operational performance; and (4) increased use of technology, data analytics, and automation at production facilities, in offices, and with customers to improve efficiencies and customer service.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedMD&A
The Innovation pillar includes expansions and investments in (1) the modernization and digitization of our operations network; (2) sustainability-driven innovation, which encompasses the full range of products, solutions, capabilities, and commitments to serve both customer needs and farmer resilience; and (3) growth initiatives, including organic growth with additional capacity to meet growing market demand and strategic objectives.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedMD&A
The Culture pillar focuses on building capabilities and enabling collaboration, teamwork, and agility from process standardization and digitalization, and bringing new perspectives and expertise to the Company’s decision-making.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedMD&A
ADM plans to support the three pillars with investments in technology, which include expanding digital capabilities and investing further in research and development.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedMD&A
Sustainability is a key driver in ADM’s expanding portfolio of environmentally responsible, plant-derived products. Consumers today increasingly expect their food and drink to come from sustainable ingredients, produced by companies that share their values, and ADM is continually finding new ways to meet those needs through its portfolio actions.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedMD&A
The Company has historically disclosed in the footnotes to its financial statements that intersegment sales have been recorded at amounts approximating market. In connection with the Company’s previously disclosed internal investigation regarding certain accounting practices and procedures with respect to its Nutrition reporting segment, including as related to certain intersegment sales (the “Investigation”) the Company identified certain intersegment sales that occurred between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments that were not recorded at amounts approximating market. The Company corrected those errors in its fiscal year 2023 Form 10-K, along with subsequently identified errors that the Company corrected in an amendment to its Annual Report on Form 10‑K for the fiscal year ended December 31, 2023 (the “FY2023 10-K/A”), and its Form 10-Qs for the first and second quarters of 2024, all of which were filed on November 18, 2024, to restate the segment information disclosure included in those filings.

Read it in 10-K 2025-02-20 at sec.gov ↗

RemovedMD&A
As previously disclosed, the Company is under investigation by the United States Securities and Exchange Commission (“SEC”) and the Department of Justice (“DOJ”) relating to, among other things, intersegment sales between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments. The Company is continuing to cooperate with the SEC and DOJ investigations and is unable to predict the outcome of these investigations.

Read it in 10-K 2025-02-20 at sec.gov ↗

Next Related parties →